CVS vs HUM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVS is a Buy and HUM is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVS’s FA Score shows that 2 FA rating(s) are green whileHUM’s FA Score has 2 green FA rating(s).
- CVS’s FA Score: 2 green, 3 red.
- HUM’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVS’s TA Score shows that 4 TA indicator(s) are bullish while HUM’s TA Score has 4 bullish TA indicator(s).
- CVS’s TA Score: 4 bullish, 5 bearish.
- HUM’s TA Score: 4 bullish, 5 bearish.
Price Growth
CVS (@Managed Health Care) experienced а -1.03% price change this week, while HUM (@Managed Health Care) price change was +1.27% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was -3.00%. For the same industry, the average monthly price growth was -3.36%, and the average quarterly price growth was +0.82%.
Reported Earning Dates
CVS is expected to report earnings on Jul 30, 2025.
HUM is expected to report earnings on Jul 30, 2025.
Industries' Descriptions
@Managed Health Care (-3.00% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CVS | HUM | CVS / HUM | |
| Capitalization | 100B | 42.4B | 236% |
| EBITDA | 18.2B | N/A | - |
| Gain YTD | 50.247 | 5.912 | 850% |
| P/E Ratio | 12.33 | 17.57 | 70% |
| Revenue | 358B | 106B | 338% |
| Total Cash | 11.5B | 21.3B | 54% |
| Total Debt | 79.4B | 12B | 662% |
CVS | HUM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 70 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 31 Undervalued | |
PROFIT vs RISK RATING 1..100 | 72 | 100 | |
SMR RATING 1..100 | 81 | 99 | |
PRICE GROWTH RATING 1..100 | 43 | 58 | |
P/E GROWTH RATING 1..100 | 10 | 15 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (5) in the Drugstore Chains industry is in the same range as HUM (31) in the Managed Health Care industry. This means that CVS’s stock grew similarly to HUM’s over the last 12 months.
CVS's Profit vs Risk Rating (72) in the Drugstore Chains industry is in the same range as HUM (100) in the Managed Health Care industry. This means that CVS’s stock grew similarly to HUM’s over the last 12 months.
CVS's SMR Rating (81) in the Drugstore Chains industry is in the same range as HUM (99) in the Managed Health Care industry. This means that CVS’s stock grew similarly to HUM’s over the last 12 months.
CVS's Price Growth Rating (43) in the Drugstore Chains industry is in the same range as HUM (58) in the Managed Health Care industry. This means that CVS’s stock grew similarly to HUM’s over the last 12 months.
CVS's P/E Growth Rating (10) in the Drugstore Chains industry is in the same range as HUM (15) in the Managed Health Care industry. This means that CVS’s stock grew similarly to HUM’s over the last 12 months.
| CVS | HUM | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 74% | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 59% | 2 days ago 56% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 56% |
| TrendWeek ODDS (%) | 2 days ago 57% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 54% | 2 days ago 59% |
| Advances ODDS (%) | 2 days ago 62% | 2 days ago 58% |
| Declines ODDS (%) | 5 days ago 58% | 5 days ago 62% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 64% |
| Aroon ODDS (%) | 2 days ago 53% | N/A |
CVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVS has been loosely correlated with CNC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CVS jumps, then CNC could also see price increases.